Cheryl Gault
Director de Operaciones en Rapport Therapeutics, Inc. .
Cargos activos de Cheryl Gault
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Director de Operaciones | 07/09/2023 | - |
Historial de carrera de Cheryl Gault
Antiguos cargos conocidos de Cheryl Gault.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Director de Operaciones | 01/01/2021 | 28/07/2023 |
| Corporate Officer/Principal | 01/05/2020 | 01/01/2021 | |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2011 | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Ventas & Marketing | - | - |
Formación de Cheryl Gault.
| Boston College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Cheryl Gault
- Experiencia
